Advertisement

Topics

Postlicensure Safety Surveillance of Shingrix

07:00 EST 22 Feb 2019 | Medscape

Are early safety monitoring findings for recombinant zoster vaccine (Shingrix) consistent with prelicensure clinical trial data?
Morbidity & Mortality Weekly Report

Original Article: Postlicensure Safety Surveillance of Shingrix

NEXT ARTICLE

More From BioPortfolio on "Postlicensure Safety Surveillance of Shingrix"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...